Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
Active & Responsive
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
for
Aggressive Variant Prostate Carcinoma
Location: Milwaukee WI
Sponsor: Deepak Kilari
Sex: Male
Age: 18+
Code: NCT07218666
Phase2, Recruiting
Active & Responsive
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
for
Cystic Fibrosis (CF), New Diagnostics
Location: Milwaukee WI, Minneapolis MN, St Louis MO,
Sponsor: Chris Goss
Sex: All
Age: 16+
Code: NCT07312734
Recruiting
Active & Responsive
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
for
Amputation, Amputation of Lower Limb, Amputation of Upper Limb,
Location: Milwaukee WI, Columbus OH, Greenville SC, New York NY,
Sponsor: AtriCure, Inc.
Sex: All
Age: 18+
Code: NCT06908538
Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Milwaukee WI, Chicago IL, Iowa City IA, Cincinnati OH,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: Glendale WI, Willowbrook IL, Detroit MI, Columbus OH,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07137598
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Wauwatosa WI, Kenosha WI, Chicago IL, Lombard IL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Greenfield WI, Chicago IL, East Lansing MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06744920
Phase3, Recruiting
Active & Responsive
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Chicago IL, Arlington Heights IL, Madison WI, Peoria IL,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase3, Recruiting
Active & Responsive
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Lake Forest IL, Rockford IL, Geneva IL, Chicago IL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05929768
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Grayslake IL, Libertyville IL, Lake Forest IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer